AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.

Employees

Sector

Pharmaceuticals

Calendar

04-30 Earnings release - Annual 2026

More about the company

Quotes

Date	Price	Change	Volume
23/10/26	€0.5490	+1.10%	49,499
22/10/26	€0.5430	-3.89%	75,277
21/10/26	€0.5650	+2.73%	88,107
20/10/26	€0.5500	+1.66%	44,337
19/10/26	€0.5410	-0.37%	60,975

Real-time Euronext Paris

More quotes

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - AB Science

Company calendar

Market Closed - Euronext Paris 16:55:00 23/10/2026 BST			5-day change	1st Jan Change
0.5490 ^EUR	+1.10%		+1.10%	-64.26%

10-09	AB Science S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
10-05	Weekly earnings calendar: PepsiCo kicks off the quarterly marathon

Market Cap	43.93M 49.19M 40.58M 36.78M 68.8M 4.67B 69.94M 488M 193M 2.45B 185M 181M 7.71B	P/E 2024	-5.88x	P/E 2025	-51.2x
Enterprise Value	53.19M 59.56M 49.14M 44.53M 83.31M 5.65B 84.69M 591M 234M 2.96B 224M 219M 9.34B	EV / Sales 2024	63.5x	EV / Sales 2025	103x
Free-Float	72.33%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Euronext Paris	AB	Real-time
Börse Stuttgart	A8D	Delayed
CBOE	ABp	Real-time
Tradegate	A8D	Real-time
Deutsche Boerse AG	A8D	Delayed
CBOE	0Q77	Real-time
Boerse Muenchen	A8D	Real-time

10-09	AB Science S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
10-05	Weekly earnings calendar: PepsiCo kicks off the quarterly marathon
10-01	Certain Ordinary Shares of AB Science S.A. are subject to a Lock-Up Agreement Ending on 1-OCT-2026.	CI
09-29	AB Science Reports Good Clinical Practice Inspection from Authorities in France, Denmark, Greece	MT
09-29	AB Science S.A. Considers Adapted Development Plan For AB8939 And Masitinib Clinical Studies	CI
09-11	Certain Ordinary Shares of AB Science S.A. are subject to a Lock-Up Agreement Ending on 11-SEP-2026.	CI
08-17	AB Science completes settlement and delivery of its private placement
08-10	AB Science Wraps Up EUR14 Million Private Placements	MT
08-10	AB Science raises €14.2m
07-13	AB Science to Discontinue Three Masitinib-related Clinical Studies	MT
07-10	AB Science streamlines its portfolio and refocuses on two molecules
07-10	AB Science SA Provides Update on Clinical Program, Suspends Non-Priority Clinical Trials and Focuses on Ab8939 and Masitinib Programs	CI
07-08	Stéphane Ledermann takes the helm at AB Science as CEO

AB Science Share Price

Stocks

AB

FR0010557264

Pharmaceuticals

Valuation: AB Science

Chart: AB Science

Latest news: AB Science

Last Transcript: AB Science

Press Releases: AB Science

News in other languages: AB Science

Quotes and Performance

Price Extremes

Managers and Directors: AB Science

Latest insider transactions

Specialty & Advanced Pharmaceuticals

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

10-12	AB Science will hold a web conference on Wednesday, October 14, 2026, from 6:00 p.m. to 7:30 p.m.	GL
10-09	AB Science : Revenues for the first half of 2026 and update on AB Science’s activities	PU
10-09	AB Science today reports its revenues for the first half of 2026 and provides an update on its activities	GL
09-29	AB Science provides an update on its development plan and financial calendar following a sponsor Good Clinical Practice inspection	GL
08-17	AB Science announces the successful settlement and delivery of securities issued as part of its €14.2 million private placement announced on August 10, 2026	GL

10-12	AB Science tiendra une web conférence le mercredi 14 octobre 2026 de 18h à 19h30
10-12	Bourse : LVMH en piste ce soir, Stellantis sort une 2CV, NVidia et Amazon s'offrent des garanties
10-12	La Bourse se découvre une passion pour le cocktail taux-croissance
10-09	AB Science annonce aujourd’hui ses résultats financiers semestriels au 30 juin 2026 et présente un point sur ses activités
10-09	Bourse : ça bouge chez Saint-Laurent (Kering) et BNP Paribas, SpaceX s'attaque aux opérateurs mobiles

1 day	+1.10%
1 week	+1.10%
Current month	-6.95%
1 month	-22.68%
3 months	+4.77%
6 months	-52.92%
Current year	-64.26%

1 week	0.53	0.58
1 month	0.51	0.7
Current year	0.5	1.61
1 year	0.5	1.61
3 years	0.5	4.46
5 years	0.5	13.76
10 years	0.5	21.75

Manager	Title	Age	Since
Stéphane Ledermann CEO	Chief Executive Officer	-	06/07/2026
Laurent Guy DFI	Director of Finance/CFO	-	19/11/2009
Christian Fassotte CTO	Chief Tech/Sci/R&D Officer	-	31/03/2018

Director	Title	Age	Since
Alain Moussy CHM	Chairman	-	10/07/2001
Patrick Moussy BRD	Director/Board Member	-	19/09/2011
Cécile de Guillebon BRD	Director/Board Member	65	26/06/2021

Date	Insider	Type	Main position	Quantity	% Market Cap.
20/05/26	Alain Moussy	Sell	Chief Executive Officer	-573	0.0009%
09/02/21	Jean-Pierre Kinet	Sell	Founder	14,525	0.0315%
02/02/21	Jean-Pierre Kinet	Sell	Founder	76,104	0.1652%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AB SCIENCE	+1.10%	+1.10%	-54.33%	-76.74%	49.19M
ELI LILLY AND COMPANY	-2.54%	+1.31%	+55.10%	+120.84%	1,135B
JOHNSON & JOHNSON	-1.42%	+3.23%	+37.07%	+74.26%	636B
ABBVIE INC.	+0.16%	+0.08%	+25.14%	+97.36%	505B
ROCHE HOLDING AG	-0.31%	+3.09%	+43.92%	+64.55%	378B
MERCK & CO., INC.	-1.34%	-0.47%	+66.63%	+40.56%	358B
NOVARTIS AG	-0.68%	+2.65%	+22.46%	+51.48%	295B
ASTRAZENECA PLC	-1.20%	+3.04%	+2.62%	+26.97%	266B
AMGEN INC.	-1.79%	+1.57%	+49.97%	+60.87%	237B
GILEAD SCIENCES, INC.	-0.73%	-0.10%	+29.24%	+101.19%	193B
Average	-0.49%	+2.06%	+27.78%	+56.13%	400.44B
Weighted average by Cap.	-0.26%	+2.66%	+40.99%	+82.13%

	2024	2025
Net sales	1.07M 1.2M 990K 897K 1.68M 114M 1.71M 11.92M 4.72M 59.71M 4.51M 4.41M 188M	1.17M 1.31M 1.08M 983K 1.84M 125M 1.87M 13.05M 5.17M 65.39M 4.93M 4.83M 206M
Net income	-7.83M -8.77M -7.23M -6.56M -12.27M -832M -12.47M -87.06M -34.47M -436M -32.91M -32.21M -1.38B	-1.56M -1.74M -1.44M -1.3M -2.44M -166M -2.48M -17.31M -6.85M -86.72M -6.54M -6.4M -273M
Net Debt	10.48M 11.74M 9.69M 8.78M 16.42M 1.11B 16.69M 117M 46.14M 584M 44.06M 43.12M 1.84B	9.26M 10.37M 8.56M 7.75M 14.51M 984M 14.75M 103M 40.76M 516M 38.92M 38.09M 1.63B